乐胖代购免代理版

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:42:27Z","timestamp":1726432947183},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.compbiomed.2023.106605","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:00:56Z","timestamp":1674543656000},"page":"106605","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modeling the effect of glucagon on endogenous glucose production in type 1 diabetes: On the role of glucagon receptor dynamics"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"http:\/\/orcid.org\/0000-0003-2923-6618","authenticated-orcid":false,"given":"Clara","family":"Furi\u00f3-Novejarque","sequence":"first","affiliation":[]},{"given":"Ricardo","family":"Sanz","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0002-5843-240X","authenticated-orcid":false,"given":"Tobias K.S.","family":"Ritschel","sequence":"additional","affiliation":[]},{"given":"Asbj\u00f8rn Thode","family":"Reenberg","sequence":"additional","affiliation":[]},{"given":"Ajenthen G.","family":"Ranjan","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0003-1620-8271","authenticated-orcid":false,"given":"Kirsten","family":"N\u00f8rgaard","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9-Luis","family":"D\u00edez","sequence":"additional","affiliation":[]},{"given":"John Bagterp","family":"J\u00f8rgensen","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0001-7286-3719","authenticated-orcid":false,"given":"Jorge","family":"Bondia","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.compbiomed.2023.106605_b1","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.compbiomed.2023.106605_b2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.compbiomed.2023.106605_b3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dc17-1402","article-title":"Pharmacokinetic and pharmacodynamic characteristics of dasiglucagon, a novel soluble and stable glucagon analog","volume":"41","author":"H\u00f6velmann","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.compbiomed.2023.106605_b4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.compbiomed.2023.106605_b5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/dme.13581","article-title":"Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems","volume":"35","author":"Peters","year":"2018","journal-title":"Diabetic Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2023.106605_b6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1932296813514502","article-title":"The UVA\/PADOVA type 1 diabetes simulator: New features","volume":"8","author":"Dalla Man","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"10.1016\/j.compbiomed.2023.106605_b7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/193229681000400117","article-title":"Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes","volume":"4","author":"Wilinska","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"issue":"5 45-5","key":"10.1016\/j.compbiomed.2023.106605_b8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1152\/ajpendo.00304.2001","article-title":"Partitioning glucose distribution\/transport, disposal, and endogenous production during IVGTT","volume":"282","author":"Hovorka","year":"2002","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.compbiomed.2023.106605_b9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217301","article-title":"A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model","volume":"14","author":"Resalat","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.compbiomed.2023.106605_b10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1109\/JBHI.2016.2593630","article-title":"Modeling glucagon action in patients with type 1 diabetes","volume":"21","author":"Emami","year":"2017","journal-title":"IEEE J. Biomed. Health Inf."},{"issue":"6","key":"10.1016\/j.compbiomed.2023.106605_b11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/1932296817693254","article-title":"Cross-validation of a glucose-insulin-glucagon pharmacodynamics model for simulation using data from patients with type 1 diabetes","volume":"11","author":"Wendt","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"issue":"11","key":"10.1016\/j.compbiomed.2023.106605_b12","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2337\/dc14-0803","article-title":"Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels","volume":"37","author":"El Youssef","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.compbiomed.2023.106605_b13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10928-019-09655-2","article-title":"Mathematical modeling of the glucagon challenge test","volume":"46","author":"Masroor","year":"2019","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"20","key":"10.1016\/j.compbiomed.2023.106605_b14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ifacol.2022.09.169","article-title":"Assessment of a new model of glucagon action with glucagon receptor dynamics","volume":"55","author":"Furio-Novejarque","year":"2022","journal-title":"IFAC Proc. Vol. (IFAC-PapersOnline)"},{"issue":"4","key":"10.1016\/j.compbiomed.2023.106605_b15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/dom.12627","article-title":"Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes","volume":"18","author":"Ranjan","year":"2016","journal-title":"Diabetes, Obes. Metab."},{"issue":"6","key":"10.1016\/j.compbiomed.2023.106605_b16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1932296815609371","article-title":"Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate","volume":"9","author":"Jacobs","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"issue":"2","key":"10.1016\/j.compbiomed.2023.106605_b17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1152\/physrev.00025.2016","article-title":"The new biology and pharmacology of glucagon","volume":"97","author":"M\u00fcller","year":"2017","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.compbiomed.2023.106605_b18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI110398","article-title":"Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and \u03b2-cell glucose sensitivity from the response to intravenous glucose","volume":"68","author":"Bergman","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.compbiomed.2023.106605_b19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/152091502320798312","article-title":"Variability of insulin absorption and insulin action","volume":"4","author":"Heinemann","year":"2002","journal-title":"Diabetes Technol. Ther."},{"issue":"5","key":"10.1016\/j.compbiomed.2023.106605_b20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1152\/ajpendo.00571.2001","article-title":"A mathematical model of metabolic insulin signaling pathways","volume":"283","author":"Sedaghat","year":"2002","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.compbiomed.2023.106605_b21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1083\/jcb.70.2.261","article-title":"Membrane receptors for hormones and neurotransmitters","volume":"70","author":"Ronald Kahn","year":"1976","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.compbiomed.2023.106605_b22","series-title":"Numerical Optimization","author":"Nocedal","year":"2006"},{"issue":"1","key":"10.1016\/j.compbiomed.2023.106605_b23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0771-050X(80)90013-3","article-title":"A family of embedded Runge-Kutta formulae","volume":"6","author":"Dormand","year":"1980","journal-title":"J. Comput. Appl. Math."},{"issue":"1","key":"10.1016\/j.compbiomed.2023.106605_b24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc16-1472","article-title":"Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study","volume":"40","author":"Ranjan","year":"2017","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.compbiomed.2023.106605_b25","first-page":"2115","article-title":"Effect of repeated glucagon doses on hepatic glycogen in type 1 Diabetes: Implications for a bihormonal Closed-Loop system","volume":"38","author":"Castle","year":"2015"},{"key":"10.1016\/j.compbiomed.2023.106605_b26","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00195","article-title":"A novel synthetic model of the glucose-insulin system for patient-wise inference of physiological parameters from small-size OGTT data","volume":"8","author":"Contreras","year":"2020","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T20:19:49Z","timestamp":1677442789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482523000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"alternative-id":["S0010482523000707"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106605","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the effect of glucagon on endogenous glucose production in type 1 diabetes: On the role of glucagon receptor dynamics","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106605"}}